BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
7 results:

  • 1. Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements.
    Orzechowska BU; Wróbel G; Turlej E; Jatczak B; Sochocka M; Chaber R
    Int Immunopharmacol; 2020 Feb; 79():106114. PubMed ID: 31881375
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.
    Stefka AT; Johnson D; Rosebeck S; Park JH; Nakamura Y; Jakubowiak AJ
    Cancer Med; 2020 Jan; 9(1):324-334. PubMed ID: 31714026
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Impact of p27
    Sengul Aycicek G; Aydogan BI; Sahin M; Cansız Ersoz C; Sak SD; Baskal N
    Endocr Pathol; 2018 Sep; 29(3):250-258. PubMed ID: 29589297
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/cdkn1b signaling.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Shen H
    Mol Carcinog; 2017 Oct; 56(10):2279-2289. PubMed ID: 28543546
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Myc targets Cks1 to provoke the suppression of p27kip1, proliferation and lymphomagenesis.
    Keller UB; Old JB; Dorsey FC; Nilsson JA; Nilsson L; MacLean KH; Chung L; Yang C; Spruck C; Boyd K; Reed SI; Cleveland JL
    EMBO J; 2007 May; 26(10):2562-74. PubMed ID: 17464290
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutational analysis of the cell cycle inhibitor kip1/p27 in childhood leukemia.
    Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
    Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
    Naka T; Boltze C; Kuester D; Schulz TO; Schneider-Stock R; Kellner A; Samii A; Herold C; Ostertag H; Roessner A
    Cancer; 2005 Sep; 104(6):1255-63. PubMed ID: 16078265
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.